Milestone Scientific
Computer-controlled dental and epidural injection systems with pressure feedback.
Something off on this page? Send us feedback.
Profile
Builds computer-controlled dental-anesthesia and epidural-injection systems using Dynamic Pressure Sensing, earning revenue from instruments and single-use handpieces. Dental supplies nearly all product sales, while Medical commercialization depends on adoption, reimbursement, and regulatory clearance.
Builds computer-controlled injection systems using Dynamic Pressure Sensing, which regulates fluid flow and measures pressure at the needle tip in real time. Dental offerings include CompuDent and the STA Single Tooth Anesthesia System with single-use The Wand handpieces; Medical offerings include CompuFlo Epidural and CathCheck.
Earns revenue from instruments and recurring handpieces. Dental sales reach U.S. offices directly through e-commerce and distributors abroad, while Medical uses a direct-and-agent U.S. model and third-party distributors internationally. Manufacturing is outsourced, with dental handpieces sourced from China.
Operates Dental and Medical segments, with Dental providing almost all product sales. Medical adoption depends on clinician acceptance, jurisdiction-specific reimbursement, regulatory clearance, and distribution capability; the principal handpiece supplier is a related party.
Company facts
Key statistics
Year to date +70.8% · Average volume (30d) 166.8K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026Q2 FY26 | −$0.01 | −$0.01 | 0.0% | $2.7M | $2.8M | +5.2% | −10.47% |
| May 13, 2026Q1 FY26 | −$0.02 | −$0.01 | +33.3% | $2.3M | $2.2M | −4.0% | −4.25% |
| Mar 31, 2026Q4 FY25 | −$0.02 | −$0.02 | −33.3% | $2.3M | $2.1M | −10.6% | +3.68% |
| Nov 13, 2025Q3 FY25 | −$0.02 | −$0.01 | +33.3% | $2.3M | $2.4M | +2.2% | −13.09% |
Financial highlights
| 11 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.3M | $2.4M | $2.1M | $2.2M | $2.8M | |
| Gross profit | $1.6M | $1.6M | $1.6M | $1.5M | $1.5M | $1.9M | |
| Operating income | −$2.0M | −$1.5M | −$1.1M | −$1.1M | −$828.1K | −$1.1M | |
| Net income | −$2.0M | −$1.5M | −$1.2M | −$1.1M | −$839.9K | −$1.1M | |
| Diluted EPS | −$0.02 | −$0.02 | −$0.01 | −$0.01 | −$0.01 | −$0.01 | |
| Gross margin | 73.8% | 69.6% | 68.7% | 72.0% | 71.4% | 67.2% | |
| Operating margin | -89.5% | -63.9% | -48.1% | -52.5% | -38.3% | -37.4% |
Fiscal years (4-quarter sums)FY24 $8.6M · FY25 $9.0M
Balance sheet, Jun 30, 2026Cash & short-term investments $2.1M · Total debt $615.7K · Total assets $8.3M · Shareholders' equity $3.5M
Dividends
No dividends on record.
Ownership
Shares outstanding 88.45M · Float 70.62M · 79.8% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Bp4 S.r.l. | 9.67M | 12.35% | 13D | Feb 7, 2025 |
| Vanguard Capital Management LLC | 1.99M | 2.25% | 13F | May 15, 2026 |
| Geode Capital Management, LLC | 616.6K | 0.70% | 13F | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 321.6K | 0.36% | 13F | May 8, 2026 |
| Citadel Advisors LLC | 167.1K | 0.19% | 13F | May 15, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- Dentsply Sirona
Computer-controlled dental anesthesia for the same practices.
- BD
Conventional epidural trays and loss-of-resistance workflow.
- Teleflex
Epidural catheter trays and loss-of-resistance workflow.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Milestone Scientific | $0.5099 | +2.95% | $44.4M | — | — | 4.7 | +22.3% |
| Dentsply Sirona | $11.13 | +0.09% | $2.23B | — | 7.5 | 0.6 | −4.1% |
| BD | $189.00 | −0.27% | $52.22B | 57.1 | 14.3 | 2.5 | −9.6% |
| Teleflex | $139.67 | −0.01% | $6.18B | — | 15.2 | 2.4 | −27.0% |
| Median | 57.1 | 14.3 | 2.4 | −9.6% |